Young researchers develop antibacterial materials

FAU receives 900,000 euros in funding for training project

Developing highly effective antibacterial biomaterials that can be used in medicine is a key priority in materials science. FAU’s Chair of Biomaterials is to receive 954,782 euros in funding from the European Union to train young researchers to work on developing such materials.

FAU is one of ten collaborators from research, medicine and industry participating in the EU project ‘Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications’ (HyMedPoly) which aims to train doctoral candidates. Five of a total of fifteen young researchers will be based at FAU as part of the EU project.

Biomedical polymer compounds are already used in many medical applications in conjunction with medications. The challenge for researchers is to develop functional materials with antibacterial properties that allow them to be used in wound care or in implants.

‘This EU training programme for doctoral candidates is very attractive to young researchers as their research projects also allow them direct access to industry in an important area of biomaterials research that is in high demand,’ explains Prof. Dr. Aldo R. Boccaccini. ‘Our goal is to train highly qualified researchers who will play a key role in research into new antibacterial biomaterials for implants, prosthetics and wound healing.’

The project will be launched at FAU in June.

Further information:

Prof. Dr. Aldo R. Boccaccini
Phone: +49 9131 8528601
aldo.boccaccini@ww.uni-erlangen.de